United States v. Sharp

400 F. App'x 741
CourtCourt of Appeals for the Fourth Circuit
DecidedNovember 5, 2010
Docket09-4932
StatusUnpublished
Cited by6 cases

This text of 400 F. App'x 741 (United States v. Sharp) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Sharp, 400 F. App'x 741 (4th Cir. 2010).

Opinion

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Dr. John C. Sharp (“Sharp”) appeals his convictions upon twenty-nine counts of health care fraud, in violation of 18 U.S.C. § 1347. On appeal, Sharp alleges numerous errors, which this Court has construed 1 as including, but not limited to: that the district court abused its discretion by allowing certain statistical evidence at trial and by allowing testimony from a non-physician medical billing and coding expert, that Sharp was deprived of his right to testify on his own behalf, prosecutorial misconduct, that certain counts in the indictment were time-barred, and that § 1347 was inapplicable. For the following reasons, we affirm the district court’s judgment.

I.

Sharp was a doctor of osteopathic medicine and licensed to practice in the state of West Virginia. He operated a general family practice medical clinic under the name Pocahontas Medical Clinics (“PMC”).

Sharp was enrolled as a provider with Medicare, Medicaid, and the West Virginia Workers’ Compensation Program (‘WVWC”). These third party payers pay claims using a national billing coding practice based on the Physicians’ Current Procedural Terminology (“CPT”) system, which is published in the AMA Current Procedural Terminology Manual (“CPT Manual”). The CPT Manual provides codes for each of the services provided to the program’s beneficiaries by the provider, with descriptions of each. The codes are meant to account for the length of the doctor’s visit with the patient, the complexity involved in the medical decision making, and the patient’s medical history.

Each of the counts against Sharp charged that he knowingly and fraudulently misused the billing codes. The charges represent three general schemes: (1) the fraudulent misuse of so-called “prolonged services” codes, which are codes that are *744 used for a visit that requires face-to-face time with the patient that is longer than the typical time spent rendering that type of procedure or service; (2) “upcoding,” or submitting claims for a “higher” level service than the one actually rendered; and (3) billing for services not rendered.

During trial, the Government called two expert witnesses whose testimonies are relevant to this appeal. The first was Betty Stump (“Stump”), a medical coding and billing expert. In sum, Stump testified that she reviewed the office visit progress notes maintained by Sharp and determined that Sharp’s billings were not supported by the documentation. The Government also called Dr. Klaus Miescke (“Miescke”), a statistician. Because Sharp submitted over 15,000 claims to the third party payers during the relevant time period, the Government asked Miescke to “select a statistically valid random sample” of the claims to determine the estimated total amount of loss to Medicare and Medicaid. (Appellee’s Br. 11).

At the conclusion of trial, the jury returned a verdict convicting Sharp on all counts, and he was sentenced to 36 months’ imprisonment.

Sharp moved for a new trial, or in the alternative, for a judgment of acquittal, alleging multiple errors which included ineffective assistance of counsel, that certain counts of the superseding indictment were time-barred, prosecutorial misconduct, that 18 U.S.C. § 1347 was inapplicable to worker’s compensation programs, that the district court erred by allowing Miescke’s and Stump’s testimonies, insufficiency of the evidence, that the district court erred by not including a proposed jury instruction, and challenges to several trial rulings. After holding a post-trial hearing, the district court denied Sharp’s motion in a written order.

Sharp noted a timely appeal, and this Court has jurisdiction over the appeal pursuant to 28 U.S.C. § 1291 and 18 U.S.C. § 3742(a).

II.

A.

Sharp argues that the district court erred by allowing certain expert testimony at trial; namely, that Miescke’s use of statistical extrapolation to estimate loss was allowed in error, and that Stump’s testimony was allowed in error because she is not a physician. 2

This Court reviews a district court’s evi-dentiary rulings, including rulings on the admissibility of expert testimony, for abuse of discretion. Gen. Elec. Co. v. Joiner, 522 U.S. 136, 141-42, 118 S.Ct. 512, 139 L.Ed.2d 508 (1997). “The question of whether expert testimony is admissible is within the sound discretion of the trial judge, and appellate courts normally defer to the trial judge’s decision.” Persinger v. Norfolk & W. Ry. Co., 920 F.2d 1185, 1187 (4th Cir.1990).

1.

Before trial, Sharp moved to exclude Miescke’s testimony, arguing during a pretrial Daubert hearing that “it is inappropriate at the count phase for there to be extrapolation testimony that goes to the *745 amount of the loss.... [T]hat is a sentencing issue, if we ever get there .... ” (J.A. 422). The district court considered the issue and decided to allow the testimony.

Sharp raised the issue again in his motion for a new trial or for acquittal. The district court held that, “[a]fter weighing the parties’ arguments, [the district court] has no trouble concluding that Dr. Miescke’s statistical testimony was properly admitted, ... and survives the defendant’s challenge under Federal Rule of Evidence 403 because its probative value substantially outweighed any unfair prejudice to the defendant.” (J.A. 323).

Although Miescke’s statistical evidence would also have been appropriate during the sentencing phase of the trial, we find that the district court did not abuse its discretion by allowing the testimony during trial. See United States v. Rosin, 263 Fed.Appx. 16, 21 (11th Cir.2008) (unpublished) (mentioning the use of similar testimony during trial). First, we note that Miescke “provide[d] a valid foundation” for his conclusions by explaining how he reviewed the claims, the statistical methods he used, and how he arrived at his proposed estimate of loss. Cooper v. Smith & Nephew, Inc., 259 F.3d 194, 200 (4th Cir.2001); see Fed.R.Evid. 702. Indeed, Sharp does not contest Miescke validly qualified as an expert witness nor does Sharp contend Miescke applied statistically invalid methods. 3

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Blythe v. USA - 2255
D. Maryland, 2023
Plymail v. Mirandy
S.D. West Virginia, 2019
State v. Robinson
363 P.3d 875 (Supreme Court of Kansas, 2015)
Ciampi v. United States
813 F. Supp. 2d 237 (D. Massachusetts, 2011)
Sharp v. United States
179 L. Ed. 2d 503 (Supreme Court, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
400 F. App'x 741, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-sharp-ca4-2010.